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In-vitro assessment of antibiotic combinations
against multidrug resistant gram negative
bacilli in South India: A save carbapenem
campaign
R. Tellis
yenepoya medical college, Mangalore, karnataka,
India
Background: Infections caused by MDR pathogens are a thera-
peutic challenge being resistant to most of the available antibiotics
and carbapenem mono-therapy is often used to treat these infec-
tions. Because resistance to carbapenems is increasing, there is a
need to explore the potential of combination antibiotic therapy.
As clinical data to support the choice of antibiotic combinations
are sparse and conﬂicting, antibiotics in combination regimen are
selectedbasedon intuition andanecdotal reports and this approach
is poorly guided, as the antibiotic combination selected may not
always be optimal, because different combinations may be asso-
ciated with different killing activity against MDR pathogens. This
study aims todetermine in-vitro efﬁcacyof antibiotic combinations
devoid of carbapenems, which will reveal the potential synergy
between two antibiotics belonging to different chemical classes,
especially when resistance to any one of them is present. Out-
come of this study is expected to help in drafting robust in-house
antibiotic policy and ease the pressure off carbepenems which are
currently used overwhelmingly in clinical practice.
Methods&Materials: This is a prospective, experimental study
where antibiogram of 85 MDR-GNB isolated from clinical sam-
ples was analysed. Minimum Inhibitory Concentration (MIC) of
ceftazidime, amikacin, imepenem and ciproﬂoxacin for these bac-
teria was determined by broth micro-dilution according to CLSI
guidelines. In-vitro effect of antibiotic combinations: CAZ- AMK,
CAZ-CIPRO, IMP-AMK and IMP-CIPRO was studied by checker-
board assay.
Results: 62.35%, 27.05% and 44.70% of these MDR-GNB
were ESBL, AmpC and MBL producers respectively. 27.05% co-
produced multiple -lactamases. MIC90 ranges for Ceftazimine
:16- ≥1028g/ml, Amikacin: 0.25 - ≥256g/ml, Ciproﬂoxacin:
0.25-128g/ml and Imepenem: 0.125-512g/ml. CAZ- AMK and
IMP-AMK combinations showed synergistic effect in 80%-90% of
MDR-GNB with FICI value of ≤0.5. Higher rates of indifference (0.5
> FICI ≤2) and antagonism (FICI > 2) were observed with combina-
tions having ﬂuroquinolones.
Conclusion: In-vitro antimicrobial activity of antibiotic com-
binations having 3rd or 4th generation cephalosporin with
aminoglycosides was comparable to that of imepenem mono-
therapy or combination and could be used to trea severe infections
caused by MDR-GNB. Therefore combinations devoid of carbepen-
ems should be advocated to prolong the clinical usefulness of this
antibiotic group.
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Prevalence of plasmid-mediated quinolone
resistance genes among ciproﬂoxacin-resistant
clinical isolates of enterobacteriaceae over four
years: A descriptive study
Y. Thiyagarajan ∗, B. Harish
Jawaharlal I nstitute of Medical Education &
Research (JIPMER), Pondicherry, India
Background: Plasmid-mediated quinolone resistance (PMQR)
has received considerable attention recently. Data analysis in
JIPMER revealed 85% of the Enterobacteriaceae isolates to be
ciproﬂoxacin-resistant in 2012. Few reports regarding the preva-
lence of PMQR are available from India. Hence, the present study
was carried out to ascertain the prevalence of PMQR genes among
ciproﬂoxacin-resistant clinical isolates belonging to family Enter-
obacteriaceae.
Graphical representation of annual ciproﬂoxacin consump-
tion and frequency of PMQR isolates for three years in JIPMER.
Methods&Materials: A total of 790 Enterobacteriaceae clinical
isolates resistant to ciproﬂoxacin bydisk diffusion andagar dilution
were studied. The isolates were screened for PMQR genes, and the
positive isolateswere further tested for the integrons intI1and intI2.
The hospital’s annual consumption data for ﬂuoroquinolones were
retrieved from JIPMER Pharmacy.
Distribution of PMQR genes across the bacterial isolateswith
different MIC values.
Results: Most strains exhibited high MIC values with 18% (150)
showing MICs >256g/mL. Overall, PMQR genes were detected in
525 (66%) isolates with 50 (6%) isolates carrying multiple PMQR
genes. PMQR frequencies were as follows; aac(6’)-Ib-cr 414 (64%),
qnrB 97 (15%), and qnrS 64 (10%). Remarkably, 15 isolates were
found positive for the single mutant variant of aac(6’)-Ib that was
conﬁrmed by sequencing. The nucleotide sequences of the PMQR
genes reported in our study are available in GenBank (KR080534
- KR080546). Variant alleles of PMQR genes were not found based
on the pair-wise distance matrix analysis. None of the strains were
positive for qnrA & qnrD. This study excluded qnrC allele. The fre-
quencies of intI1 and intI2 among the PMQR isolates were 35% and
